Compile Data Set for Download or QSAR
Report error Found 51 Enz. Inhib. hit(s) with all data for entry = 7081
TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173248BDBM173248(US9096595, 51)
Affinity DataIC50: 0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173207BDBM173207(US9096595, 10)
Affinity DataIC50: 0.700nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173244BDBM173244(US9096595, 47)
Affinity DataIC50: 0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173229BDBM173229(US9096595, 32)
Affinity DataIC50: 0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173246BDBM173246(US9096595, 49)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173247BDBM173247(US9096595, 50)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173217BDBM173217(US9096595, 20)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173242BDBM173242(US9096595, 45)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173238BDBM173238(US9096595, 41)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173206BDBM173206(US9096595, 9)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173230BDBM173230(US9096595, 33)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173245BDBM173245(US9096595, 48)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173240BDBM173240(US9096595, 43)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173235BDBM173235(US9096595, 38)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173243BDBM173243(US9096595, 46)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173241BDBM173241(US9096595, 44)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173236BDBM173236(US9096595, 39)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173214BDBM173214(US9096595, 17)
Affinity DataIC50: 4nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173228BDBM173228(US9096595, 31)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173237BDBM173237(US9096595, 40)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173221BDBM173221(US9096595, 24)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173215BDBM173215(US9096595, 18)
Affinity DataIC50: 6nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173218BDBM173218(US9096595, 21)
Affinity DataIC50: 7nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173200BDBM173200(US9096595, 3)
Affinity DataIC50: 8nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173225BDBM173225(US9096595, 28)
Affinity DataIC50: 8nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173231BDBM173231(US9096595, 34)
Affinity DataIC50: 9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173199BDBM173199(US9096595, 2)
Affinity DataIC50: 9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173201BDBM173201(US9096595, 4)
Affinity DataIC50: 9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173219BDBM173219(US9096595, 22)
Affinity DataIC50: 9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173227BDBM173227(US9096595, 30)
Affinity DataIC50: 10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173232BDBM173232(US9096595, 35)
Affinity DataIC50: 11nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173205BDBM173205(US9096595, 8)
Affinity DataIC50: 12nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173223BDBM173223(US9096595, 26)
Affinity DataIC50: 16nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173202BDBM173202(US9096595, 5)
Affinity DataIC50: 16nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173204BDBM173204(US9096595, 7)
Affinity DataIC50: 17nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173198BDBM173198(US9096595, 1)
Affinity DataIC50: 21nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173213BDBM173213(US9096595, 16)
Affinity DataIC50: 21nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173234BDBM173234(US9096595, 37)
Affinity DataIC50: 27nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173211BDBM173211(US9096595, 14)
Affinity DataIC50: 42nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173216BDBM173216(US9096595, 19)
Affinity DataIC50: 51nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173233BDBM173233(US9096595, 36)
Affinity DataIC50: 65nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173239BDBM173239(US9096595, 42)
Affinity DataIC50: 71nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173203BDBM173203(US9096595, 6)
Affinity DataIC50: 92nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173212BDBM173212(US9096595, 15)
Affinity DataIC50: 136nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173222BDBM173222(US9096595, 25)
Affinity DataIC50: 141nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173209BDBM173209(US9096595, 12)
Affinity DataIC50: 231nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173220BDBM173220(US9096595, 23)
Affinity DataIC50: 354nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173210BDBM173210(US9096595, 13)
Affinity DataIC50: 417nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173208BDBM173208(US9096595, 11)
Affinity DataIC50: 420nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 173224BDBM173224(US9096595, 27)
Affinity DataIC50: 812nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: